-
Study aim
-
Determining the effect of injectable Caffeine on reducing pain after surgery in laparoscopic Cholecystectomy
-
Design
-
A clinical trial with a control group, with parallel groups, three-blind, on 60 patients, Randomized by the method of Balanced Block Randomization
-
Settings and conduct
-
This study is conducted on candidates for laparoscopic Cholecystectomy referring to educational-therapeutic centers of Qazvin University of Medical Sciences. After training and informed consent, they are randomly assigned to the experimental group or the control group. Demographic information is entered into the checklist. The experimental group is injected with Caffeine and the control group is injected with Normal Saline. The pain level of the patient is recorded 10, 30, and 60 minutes after the intervention. If the patient has pain, Pethidine is injected. The amount of pain and the amount of Pethidine in both groups will be compared. The medicine is in closed-coded envelopes. The anesthesiologist, patient, analyzer, and project manager are blinded.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: candidate for Cholecystectomy in the age range of 15-60; non-inclusion criteria: pregnancy and breastfeeding and abortion; smoking, alcohol, and drugs; chronic mental and physical illness; Disabilities; taking Corticosteroid, antihistamine, and painkillers; Allergy to Caffeine and Pethidine; history of surgery.
-
Intervention groups
-
After entering recovery, the experimental group is injected with Caffeine at a dose of 1 mg/kg, and the control group is injected 3cc of Normal Saline. The pain level of the patient is recorded 10, 30, and 60 minutes after the intervention. For pain intensity between 4 and 6, 0.25 mg/kg of Pethidine, and between 7 and 10, 0.5 mg/kg of Pethidine is injected.
-
Main outcome variables
-
Pain score; Dosage of Pethidine